000			01673 a2200493 4500
005			20250517165044.0
264		0	_c20180524
008			201805s 0 0 eng d
022			_a1099-1557
024	7		_a10.1002/pds.4279 _2doi
040			_aNLM _beng _cNLM
100	1		_aValent, Francesca
245	0	0	_aNew oral anticoagulant prescription rate and risk of bleeding in an Italian region. _h[electronic resource]
260			_bPharmacoepidemiology and drug safety _cOct 2017
300			_a1205-1212 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdministration, Oral
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnticoagulants _xadverse effects
650	0	4	_aAtrial Fibrillation _xcomplications
650	0	4	_aCase-Control Studies
650	0	4	_aCross-Over Studies
650	0	4	_aDabigatran _xadverse effects
650	0	4	_aDrug Prescriptions _xstatistics & numerical data
650	0	4	_aFemale
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHospitalization _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aItaly _xepidemiology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrevalence
650	0	4	_aPyrazoles _xadverse effects
650	0	4	_aPyridones _xadverse effects
650	0	4	_aRisk Factors
650	0	4	_aRivaroxaban _xadverse effects
650	0	4	_aSex Factors
650	0	4	_aStroke _xetiology
650	0	4	_aTime Factors
773	0		_tPharmacoepidemiology and drug safety _gvol. 26 _gno. 10 _gp. 1205-1212
856	4	0	_uhttps://doi.org/10.1002/pds.4279 _zAvailable from publisher's website
999			_c27416755 _d27416755